Drug Detail
Information about NN3201
Generic Name |
||
|---|---|---|
IND |
NN3201 | |
Brand Name (US) |
||
Manufacturer |
Novelty Nobility | |
Drug Type |
monoclonal antibody | |
Delivery |
Intravenous | |
Approval Status |
Phase 1 | |
Indications |
Ckit positive cancers | |
Overall Strategy |
Modulate microtubule dynamics | |
Strategy |
Inhibit Tubulin and limit DNA replication | |
Drug Category |
cKIT Antibody Drug Conjugate | |
Links |
|
Trials of this drug |
|
|
A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/or Metastatic Solid Tumors Known to Express C-Kit |
Trial results |
|
Search for this drug/combination in: